chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 weeks ago my son present a symptoms like a fell down, temblors and dizzy. Now he have 2 seizures in one week. He never present this in the past and none family history with that.
Vaginal bleeding; Brown discharge, and it looked like a menstrual period; patient had received 1 dose of J and J vaccine and then received booster dose of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (Vaginal bleeding), VAGINAL DISCHARGE (Brown discharge, and it looked like a menstrual period) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient had received 1 dose of J and J vaccine and then received booster dose of Moderna vaccine) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058F21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: JANSSEN COVID-19 VACCINE (J and J COVID-19 vaccine - one dose) in April 2021. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE. Concurrent medical conditions included HIV disease (lived 40 years with HIV) and Menopause (patient had been in Menopause for so many years).    On 23-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient had received 1 dose of J and J vaccine and then received booster dose of Moderna vaccine). On 30-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VAGINAL HAEMORRHAGE (Vaginal bleeding) and VAGINAL DISCHARGE (Brown discharge, and it looked like a menstrual period). On 23-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient had received 1 dose of J and J vaccine and then received booster dose of Moderna vaccine) had resolved. At the time of the report, VAGINAL HAEMORRHAGE (Vaginal bleeding) and VAGINAL DISCHARGE (Brown discharge, and it looked like a menstrual period) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment medication use was not provided by the reporter.  The patient had received a booster dose of Moderna vaccine and after one week, the patient had vaginal discharge and bleeding.
Patient developed throat swelling and difficulty swallowing within minutes of receiving the vaccine.  She received EPI at the site and went to the ED where she was treated for allergic reaction.  No other organ systems were involved.  She received steroids and antihistamines.
Mom states that she had a severe reaction to varicella. Pt had shingles in throat and was in the hospital and almost died.
lightheadedness Narrative: Was seen in vaccine observation area at 10am with c/o lightheadedness; BP 97/60, HR 88. At 10:25am lightheadedness improved but upon standing she felt lightheaded again and was assisted to cart and placed in trendelenberg position. Ice pack was applied. At 11:30 vitals were 111/58, HR 75 and she was escorted per w/c back to lab to work. States that she is sitting all day and will be closer to her physician at Facility versus at home. Co workers stated that they will also look out for her is she needs assistance.
When I first noticed it my hands started feeling very full and puffy, felt very swollen. Then later that evening my lower back began hurting very badly. The pain continued and about 5 days later I finally went to the ER because my entire body was hurting so bad I couldn't drive or barely move. They never found anything wrong though. About 5 days following my first hospital visit I went back again this time to a different hospital because the pain had continued and was actually worsening to the point that I had to be carried to the bathroom and anywhere I needed to go. Unfortunately they never found anything either.
Treatment of COVID-19; Treatment of COVID-19; Moderna COVID-19 Vaccine dose 3 and Pfizer Vaccine dose 4; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Nov2022 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), in Feb2022 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Heart Failure" (unspecified if ongoing); "pre-hypertension" (unspecified if ongoing); "Known allergy: Iodine as contrast dye" (unspecified if ongoing); "sleep apnea" (unspecified if ongoing); "low testosterone" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset Nov2022, outcome "unknown", described as "Moderna COVID-19 Vaccine dose 3 and Pfizer Vaccine dose 4"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received Paxlovid (lot number: unknown) on 17Dec2022 and stopped on 22Dec2022 for treatment of COVID-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Rash on chest, back and stomach, may have ran fever last night but parent was not sure. Infant does not act like rash bothers her notice rash the next morning after vaccines.
This spontaneous report was received from a registered nurse refers to a multiple unspecified patient's of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On an multiple unspecified dates, the multiple unspecified patient's were vaccinated with improperly stored doses of RECOMBIVAX HB (lot, expiry date and dosage regimen was unknown) for a year. No adverse effects reported. No product quality complaint was filed. This is one of several reports received from the same reporter. Additional information has been requested.
tested positive for Covid19; tested positive for Covid19; This is a spontaneous report from a Pfizer-sponsored program . A contactable male consumer (patient) reported that a male patient of an unspecified age received first dose bnt162b2 (Solution for injection), via an unspecified route of administration on 01Feb2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The caller got the first dose of the Covid19 vaccine last 01Feb2021. He went to the doctor the next Friday and he got tested positive for Covid19 in 2021. He is scheduled to take the second dose of the Covid19 vaccine on 22Feb2021. He wants to know if he can get the second dose since he is already positive for Covid19.  Information on the lot/batch number has been requested.
Injection site and then 3/4 of left upper arm painful and swollen within a couple of hours. Awakened early the next morning, feeling ill. 1.5cm patch of skin had sloughed, 3cm ring about site red and edematous, upper arm swollen from just above elbow to just below deltoid.
Pain at injection site. Body aches, headache, fever (102.1 at peak), nausea, and severe cough without production. Most symptoms lasted 6 days. The cough is persistent.
MRI Brain w/wo 5/27/22 Acute thrombosis of the proximal right IJ vein and right sigmoid and  transverse sinuses, nearly completely occlusive at the sigmoid sinus.
Client had come in having had Pfizer COVID 19 on 3/20/21 and 3/25/21.  Her dr told her not to take anymore mRNA vaccines so she received a Janssen 12/16/21.  She was requesting a booster.  Immunization nurse for our clinic was consulted and we were instructed to give her another Janssen if that's what she wanted.  Janssen was give.  Later, our COVID Vaccine Specialist at our state health dept told us we should have given a Novavax or nothing.  We were instructed to complete a VAERS.  No adverse reactions reported by client.
Patient received Pfizer vaccine as his 2nd dose, instead of Moderna vaccine (1st dose was from Moderna Covid-19 vaccine)
localized rxn 2 3/4" x 3/4: redness, swelling & warmth;
approx 18 days p/vax pt exp extreme fatigue & weakness; joint & muscle pain; immunosuppression; polyneuropathy demyelination; dec LOC; tx w/IVIG, medicine, vitamin & diet
Extreme bone pain, joint pain, hand pain, skin tenderness, headache, nasal stuffiness, chills.  Extreme pain lasted from 0140- 0500, but continued with  the skin tenderness, chills, headache and joint pain.  Took Tylenol.  Got up once and thought I would pass out.  Started resting some around 7am.  Drank plenty of fluids.  Drained all day.  Saturday morning headache, nasal congestion, joint pain, hard to get out of bed.  Drained all day.  Sunday feeling better, but lethargic.  Monday back to work.
This case was reported by a nurse via call center representative and described the occurrence of weakness in a adolescent male patient who received Hepatitis B vaccine for prophylaxis. Co-suspect products included Meningitis ACWY vaccine (potential MENVEO) for prophylaxis. Concurrent medical conditions included nervous. On an unknown date, the patient received Hepatitis B vaccine at an unknown dose and Meningitis ACWY vaccine (potential MENVEO) at an unknown dose. On an unknown date, unknown after receiving Hepatitis B vaccine and Meningitis ACWY vaccine (potential MENVEO), the patient experienced weakness. On an unknown date, the outcome of the weakness was unknown. It was unknown if the reporter considered the weakness to be related to Hepatitis B vaccine and Meningitis ACWY vaccine (potential MENVEO). Additional details were provided as follows: The age at the vaccination was not reported. The health care professional reported that after the patient received Hepatitis-B and MCV4 vaccines he became weak. Brand was not specified, but likely ENGERIX-B and MENVEO. The health care professional stated that this was not a reaction to the vaccine but was a result of the patient being very nervous and the accompanying parent expressing anti-vaccine sentiment during the visit. The health care professional stated that the patient was overwhelmed. No further details were provided.
Information has been received from a nurse practitioner concerning an approximately 19 year old female patient who was vaccinated with a second dose of Gardasil. Subsequently, the patient developed symptoms of a urinary tract infection and was placed on an antibiotic. The patient was then diagnosed with pelvic inflammatory disease and was treated with FLAGYL. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
So after I got the 2nd vaccine, 1 hour after my left arm was really sore and I couldn't even turn my head on the left side, which I thought was normal at the time. Where the shot was I could feel warmth for at least 10 days. Where the needle was. it was very hot at the injection site. Since then, I?m not able to lay down on my left side or cross my arms on my body. There is a lot of pain. I can't lift arm over my head and still can't turn that. And I can't turn my head to the left fully and it feels sore from the neck to where the vaccine site is. When working out and lifting and laying down, I can't lift because of pain on the left side of body, shoulder, and arm.
5 minutes s/p vaccine #2 patient became flushed, diaphoretic and had a sustained HR of 140-150 for 30 minutes. Patient had increased blood pressure of 190/108.  Patient taken to Emergency Department for care.
Severe swelling of left arm and pain from shoulder to elbow (first 48 hours), plus extending below elbow to fingers after 48 hours. Area was very swollen, hard and warm. Took Acetaminophen (1000 mg every 6 hours) for pain - offered almost no relief. After 24 hours RPh suggested BENADRYL and ice pack. Ice pack was applied and reduced inflammation slightly. There was also headache and fever for the first 24 hours.
On 6-15-11 pt's father reported that son's left arm had a red rah around injection site. Deltoid had red, swollen, warm to the touch. Developed "flu like symptoms" fever, malaise, decreased appetite. Symptoms lasted five days.
Minor itching; Oval shaped rash; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness), VACCINATION SITE PRURITUS (Minor itching) and VACCINATION SITE RASH (Oval shaped rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (Soreness). On 24-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Minor itching) and VACCINATION SITE RASH (Oval shaped rash). On 12-Feb-2021, MYALGIA (Soreness) outcome was unknown. At the time of the report, VACCINATION SITE PRURITUS (Minor itching) and VACCINATION SITE RASH (Oval shaped rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications and treatment information were reported.
Patient had a syncopal event following administration of vaccines resulting in the patient falling, hitting head, and a brief loss of consciousness and hit side of face and broke a tooth.
Initial report was received from a consumer on 24 October 2012. A child (age not reported) received an injection of FLUZONE (Lot number, route, site, and date of vaccination was not reported) and a week later experienced elevated blood sugars. No further information was provided. The patient's outcome was unknown. Documents held by sender: None.
Pain at injection site radiating up into right jaw as chief complaint when patient presented into my office on 9/28/2021. Gave patient a Chiropractic adjustment that included working on the TMJ.  Patient returned to this office 10/5/2021 with no change in chief complaint.  Working diagnosis is ?Covid Arm?
Severe vomiting, severe migraine, incontinence, inability to stand up without vomiting. Resolved after twelve hours.
Mother noted that childs left arm was swollen, red, and hot a day after vaccination. Child was taken to facility and diagnosed with a local site reaction. Mother was instructed to give child Benadryl. Mother states that swelling and redness are better since taking the Benadryl.
Back pain, spasms, weakness, tiredness.    Treatment: Advil 800 mg
EMS WAS CALLED PATIENT BECAME WARM BUT CLAMMY, PALE AND LETHARGIC WHEN EMS ARRIVED PATIENT WAS ALERT AND RESPONSIVE
Booster shot, 4 days later Blood Pressure dropped to 70/50 and ER worked to get pressure up. Spent 3 days in ICU and 3 days in non ICU
Little tired; Foggy; Whirly imbalance while getting up to go the bathroom which went away away; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Little tired), FEELING ABNORMAL (Foggy) and BALANCE DISORDER (Whirly imbalance while getting up to go the bathroom which went away away) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Little tired), FEELING ABNORMAL (Foggy) and BALANCE DISORDER (Whirly imbalance while getting up to go the bathroom which went away away). At the time of the report, FATIGUE (Little tired), FEELING ABNORMAL (Foggy) and BALANCE DISORDER (Whirly imbalance while getting up to go the bathroom which went away away) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information does not provided .   This case was linked to MOD-2021-335705 (Patient Link).
Heart palpitations; Shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL96264) via an unspecified route of administration in the left arm on 11Feb2021 at 08:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included blood clot at age 29 and surgery to remove clot x2. Concomitant medication included ibuprofen (MOTRIN) from an unknown date and unknown if ongoing. The patient previously received morphine (MANUFACTURER UNKNOWN) taken for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Feb2021 at 16:00, about 7 hours after getting the shot, the patient had heart palpitations and shortness of breath. It lasted 13 mins and the patient ended up falling asleep for the night when the patient woke up the patient was fine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events heart palpitations and shortness of breath were recovered on 11Feb2021 at 16:13.  No follow-up attempts are needed. No further information is expected.
Primary doctor prescribes the Gardasil Vaccine. I pick it up from pharmacy and it was administrated at the medical center on April 15, 2022.  Next day pharmacy called letting us know that was an expired vaccine.  They made all the arrangements with the medical center to administer a new vaccine on April 18. Symptoms:  Chilli, headache and sore pain in the arms.
Arm became itchy, red and blotchy, hot, firm at injection site exactly one week after injection. The symptoms have lasted 2 days, so far. No treatment necessary.
No additional adverse symptoms; the patient was inadvertently administered one dose of MMR II and VARIVAX by intramuscular route, instead of the subcutaneous route; This spontaneous report was received from a pharmacist referring to a patient of unknown age. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 02-JAN-2020 the patient was inadvertently administered one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (rHA) with lot # R022423 and expiration date 06-AUG-2020 and varicella virus vaccine live (oka/merck)(VARIVAX) with lot # R029517 and expiration date 14-OCT-2020 (strength, dose, route of administration and anatomical location were unknown) via intramuscular instead of subcutaneous route for prophylaxis (incorrect route of product administration). No additional adverse symptoms were reported. There was no product quality complaint associated with the case.
PROQUAD administered 7/14/17. 7/15/17 8PM 4 cm welt at site to ER. Was advised to start Clindamycin if area grew. 7/16/17 area was 5 cm by 9AM so clindamycin was started 7/17/17 9-10 cm erythema, but a lot less red. Never with wheezing, fever nausea or vomiting acted well throughout.
Received Moderna when she was only 17. Client got a dose when she was not old enough.
This spontaneous report was received from an office manager and refers to an unknown number of unspecified adult patients of unknown gender. Since an unknown date, the patients were vaccinated with two pediatric doses of VAQTA injection, 25/0.5 (units not provided) (lot number, expiration date and route of administration were not reported). No adverse effects were reported. Additional information has been requested.
The batch was administered to patient after 12-Jan-2023, last dose given was 13-Apr-2023.; The vial which was delivered on 12-Dec-2022 was in refrigerator since then and administered to patient after 12-jan-2023 till 13-Apr-2023; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The batch was administered to patient after 12-Jan-2023, last dose given was 13-Apr-2023.), PRODUCT STORAGE ERROR (The vial which was delivered on 12-Dec-2022 was in refrigerator since then and administered to patient after 12-jan-2023 till 13-Apr-2023) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1417B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (The batch was administered to patient after 12-Jan-2023, last dose given was 13-Apr-2023.), PRODUCT STORAGE ERROR (The vial which was delivered on 12-Dec-2022 was in refrigerator since then and administered to patient after 12-jan-2023 till 13-Apr-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The batch was administered to patient after 12-Jan-2023, last dose given was 13-Apr-2023.), PRODUCT STORAGE ERROR (The vial which was delivered on 12-Dec-2022 was in refrigerator since then and administered to patient after 12-jan-2023 till 13-Apr-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The batch was administered to patient after 12-Jan-2023, last dose given was 13-Apr-2023.) and PRODUCT STORAGE ERROR (The vial which was delivered on 12-Dec-2022 was in refrigerator since then and administered to patient after 12-jan-2023 till 13-Apr-2023).    Dosage text for suspect product was reported as unknown.  Concomitant drugs were not reported.  It was reported that the Moderna Covid-19 vaccine monovalent 6months-5 years which was delivered on 12-Dec-2022 was administered to patients after 12-Jan-2023 with last dose given on 13-Apr-2023.  Treatment medications were not provided.  This case was reported for patient 4 of 6.   This case was linked to US-MODERNATX, INC.-MOD-2023-721723 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-721723:01 patient case
developed severe inflammatory response isolated to hands bilaterally. requiring steroids and numerous lab tests for diagnosis of rheumatoid arthritis requiring methotrexate, hydrochloroquine, and current biologic infusion simponi aria.
w/in 24 hrs achy, t103, lightheaded, fatigued, baseball sized welt @ inject site (arm extremly sore), very tender, red, & hot to the touch;
tachycardia and feeling flushed that started approximately within 5 minutes of the vaccine
Received vaccine in Left upper arm. Employee reports that within 1 hour the upper arm became painful and swelling with redness was going down into the elbow. Worsened the next day and has continued to stay painful, swollen and red. Reported to employee health nurse this morning that Left elbow red, hot, swollen and bodyaches, denies fevers or dyspnea. Was instructed to be seen at Hospital out patient clinic for evaluation.